The phase III clinical trial of Xinkanghe IL-17A/F antibody drug for the treatment of ankylosing spondylitis has reached its research endpoint.

Release time:

2024-12-11 08:00

None

First in class, Xinkanghe antibody drug XKH001 has been approved by the US FDA to enter clinical trials.

None

First in class, Xinkanghe antibody drug XKH001 has been approved by the US FDA to enter clinical trials.

2024-08-22

On August 21, 2024, at 15:30, the Jiangning District Market Supervision Administration came to our company for a routine inspection of the toothpaste product's market launch status.

2023 Year-End Activity and 2024 Dragon Year New Year Celebration of the Jiangsu Provincial Economic Branch II of the Agricultural Workers Party

2024-01-18

Hold the project initiation demonstration meeting for the 1.1 category innovative traditional Chinese medicine BDP-ZS-001.

2023-12-26

Ms. Yu Min donated charitable materials to the Jiangsu Provincial Women's and Children's Welfare Foundation.

2023-12-13

Home About Center of R&D Pipeline Cooperation Agency Information Center Join Contact

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Beijing Address: A203, Zhongguancun Biomedical Park, No.5, Development Road, Haidian District, Beijing
Zhejiang Address: Floor 8, Building 7, Dongsheng Huigu, 1299 Kehai Avenue, Keqiao District, Shaoxing City, Zhejiang Province
Contact Phone:010-82176552
E-mail:hr@kanovabiopharma.com

Power by：300.cn Beijing

SEO Tags

Business License